| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
1 Department of Biology, Gallaudet University, Washington, District of Columbia; Laboratories of 2 Cellular Carcinogenesis and Tumor Promotion and 3 Experimental Carcinogenesis, National Cancer Institute, NIH, Bethesda, Maryland; 4 Departments of Internal Medicine and Medicinal Chemistry and Comprehensive Cancer Center, University of Michigan, Ann Arbor, Michigan
Requests for reprints: Peter M. Blumberg, National Cancer Institute, NIH, Building 37, Room 4048, 37 Convent Drive, MSC 4255, Bethesda, MD 20892-4255. Phone: 301-496-3189; Fax: 301-496-8709. E-mail: blumberp{at}dc37a.nci.nih.gov
The diacylglycerol signaling pathway, involving protein kinase C (PKC) and RasGRP, is a promising therapeutic target for both cancer and other indications. The phorbol esters, ultrapotent diacylglycerol analogues, bind to and activate PKC and RasGRP. Here, using fluorescent phorbol esters and complementary fluorescent PKC and RasGRP constructs, we determined the localization of the phorbol ester as a function of time after addition and how the resultant PKC or RasGRP3 translocation related to ligand localization. For these studies, we prepared fluorescently labeled phorbol esters of varying lipophilicities based on the BODIPY FL (green) or BODIPY 581/591 (red) fluorophores, and by using fusion constructs of green fluorescent protein or DsRed with PKC isoforms or RasGRP3 expressed in Chinese hamster ovary cells, we simultaneously compared the kinetics and pattern of localization of PKC or RasGRP3 with that of the fluorescent red or green phorbol esters. Binding assays showed that the fluorescent derivatives were potent ligands. Uptake followed a one-compartment pharmacokinetic model with a half-time of minutes to hours, depending on the ligand, and all of the fluorescent phorbol esters localized primarily to intracellular membranes, with little plasma membrane localization. The fluorescent phorbol esters induced translocation of and generally colocalized with PKC
or RasGRP3. However, PKC
and, initially, PKC
, translocated to the plasma membrane, in which little phorbol ester accumulated. The findings argue that the rate of uptake of phorbol esters influences the subsequent pattern of PKC
translocation, and that the specificity for PKC
translocation is dominated by factors other than the localization of the ligand.
Key Words: phorbol ester protein kinase C green fluorescent protein subcellular localization, kinetics uptake
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 8/ 4/04; revised 10/15/04; accepted 11/ 8/04.
This article has been cited by other articles:
![]() |
S. M. Okamura, C. E. Oki-Idouchi, and P. S. Lorenzo The Exchange Factor and Diacylglycerol Receptor RasGRP3 Interacts with Dynein Light Chain 1 through Its C-terminal Domain J. Biol. Chem., November 24, 2006; 281(47): 36132 - 36139. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Pu, M. L. Peach, S. H. Garfield, S. Wincovitch, V. E. Marquez, and P. M. Blumberg Effects on Ligand Interaction and Membrane Translocation of the Positively Charged Arginine Residues Situated along the C1 Domain Binding Cleft in the Atypical Protein Kinase C Isoforms J. Biol. Chem., November 3, 2006; 281(44): 33773 - 33788. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kohl, S. Preiss, A. von Knethen, and B. Brune Oxidized low-density lipoprotein depletes PKC{alpha} and attenuates reactive oxygen species formation in monocytes/macrophages Cardiovasc Res, August 1, 2006; 71(3): 574 - 585. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lazar, D. C. Braun, A. Toth, Y. Wang, L. V. Pearce, V. A. Pavlyukovets, P. M. Blumberg, S. H. Garfield, S. Wincovitch, H.-K. Choi, et al. Kinetics of Penetration Influence the Apparent Potency of Vanilloids on TRPV1 Mol. Pharmacol., April 1, 2006; 69(4): 1166 - 1173. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Collazos, B. Diouf, N. C. Guerineau, C. Quittau-Prevostel, M. Peter, F. Coudane, F. Hollande, and D. Joubert A Spatiotemporally Coordinated Cascade of Protein Kinase C Activation Controls Isoform-Selective Translocation. Mol. Cell. Biol., March 1, 2006; 26(6): 2247 - 2261. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Tuthill, C. E. Oki, and P. S. Lorenzo Differential effects of bryostatin 1 and 12-O-tetradecanoylphorbol-13-acetate on the regulation and activation of RasGRP1 in mouse epidermal keratinocytes. Mol. Cancer Ther., March 1, 2006; 5(3): 602 - 610. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Wabnitz, G. Nebl, M. Klemke, A. J. Schroder, and Y. Samstag Phosphatidylinositol 3-Kinase Functions as a Ras Effector in the Signaling Cascade That Regulates Dephosphorylation of the Actin-Remodeling Protein Cofilin after Costimulation of Untransformed Human T Lymphocytes J. Immunol., February 1, 2006; 176(3): 1668 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Giorgione, J.-H. Lin, J. A. McCammon, and A. C. Newton Increased Membrane Affinity of the C1 Domain of Protein Kinase C{delta} Compensates for the Lack of Involvement of Its C2 Domain in Membrane Recruitment J. Biol. Chem., January 20, 2006; 281(3): 1660 - 1669. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |